BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30910333)

  • 1. [Primitive myxoid melanoma: An unusual histological aspect].
    Capelle C; Scherman L; Gerard A; Vicentini C; Levavasseur M; Carpentier O; Mortier L
    Ann Dermatol Venereol; 2019 May; 146(5):372-376. PubMed ID: 30910333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous melanoma with myxoid features: twelve cases with differential diagnosis.
    Hitchcock MG; McCalmont TH; White WL
    Am J Surg Pathol; 1999 Dec; 23(12):1506-13. PubMed ID: 10584704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of immunostaining using pan-melanoma cocktail, SOX10, and microphthalmia transcription factor in confirming a diagnosis of melanoma on fine-needle aspiration smears.
    Clevenger J; Joseph C; Dawlett M; Guo M; Gong Y
    Cancer Cytopathol; 2014 Oct; 122(10):779-85. PubMed ID: 24954720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX-10 and S100 Negative Desmoplastic Melanoma: Apropos a Diagnostically Challenging Case.
    Kooper-Johnson S; Mahalingam M; Loo DS
    Am J Dermatopathol; 2020 Sep; 42(9):697-699. PubMed ID: 32149837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically verrucous and histologically discohesive melanoma. A case report with dermoscopic and immunohistochemical observations.
    Ohnishi T; Hamano M; Watanabe S
    Australas J Dermatol; 2014 May; 55(2):e21-3. PubMed ID: 23530904
    [No Abstract]   [Full Text] [Related]  

  • 6. SOX10 is as specific as S100 protein in detecting metastases of melanoma in lymph nodes and is recommended for sentinel lymph node assessment.
    Szumera-Ciećkiewicz A; Bosisio F; Teterycz P; Antoranz A; Delogu F; Koljenović S; van de Wiel BA; Blokx W; van Kempen LC; Rutkowski P; Christopher van Akkooi A; Cook M; Massi D;
    Eur J Cancer; 2020 Sep; 137():175-182. PubMed ID: 32781392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of sentinel lymph node biopsy in patients with melanoma].
    Ren M; Kong YY; Cai X; Shen XX; Lyu JJ
    Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):360-365. PubMed ID: 29783803
    [No Abstract]   [Full Text] [Related]  

  • 8. Value of melanocytic-associated immunohistochemical markers in the diagnosis of malignant melanoma: a review and update.
    Ordóñez NG
    Hum Pathol; 2014 Feb; 45(2):191-205. PubMed ID: 23648379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conjunctival nevi and melanoma: multiparametric immunohistochemical analysis, including p16, SOX10, HMB45, and Ki-67.
    Milman T; Zhang Q; Ang S; Elder D; Ida CM; Salomao DR; Lally SE; Shields JA; Hamershock RA; Sioufi K; Shields CL; Eagle RC
    Hum Pathol; 2020 Sep; 103():107-119. PubMed ID: 32707054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of primary cutaneous PEComa].
    Trotot-Voilliot C; Laveine E; Beurey P; Cuny JF; Schmutz JL; Truchetet F
    Ann Dermatol Venereol; 2013 May; 140(5):373-7. PubMed ID: 23663710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A metastatic melanoma with an unusual immunophenotypic profile.
    Gao Z; Stanek A; Chen S
    Am J Dermatopathol; 2007 Apr; 29(2):169-71. PubMed ID: 17414440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cutaneous myxoid melanoma: immunohistologic clues to a difficult diagnosis.
    Prieto VG; Kanik A; Salob S; McNutt NS
    J Am Acad Dermatol; 1994 Feb; 30(2 Pt 2):335-9. PubMed ID: 8294593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic Malignant Melanoma With Complete Loss of Differentiation Markers (Undifferentiated/Dedifferentiated Melanoma): Analysis of 14 Patients Emphasizing Phenotypic Plasticity and the Value of Molecular Testing as Surrogate Diagnostic Marker.
    Agaimy A; Specht K; Stoehr R; Lorey T; Märkl B; Niedobitek G; Straub M; Hager T; Reis AC; Schilling B; Schneider-Stock R; Hartmann A; Mentzel T
    Am J Surg Pathol; 2016 Feb; 40(2):181-91. PubMed ID: 26448190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological, immunohistochemical and fluorescence in-situ hybridisation features of early subungual melanoma: an analysis of 65 cases.
    Ren M; Ren J; Cai X; Shen XX; Kong JC; Dai B; Kong YY
    Histopathology; 2021 Apr; 78(5):717-726. PubMed ID: 33065755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of melanocytic markers for immunocytochemical evaluation of lymph-node melanoma metastases on cytological samples.
    Ronchi A; Zito Marino F; Toni G; Pagliuca F; Russo D; Signoriello G; Moscarella E; Brancaccio G; Argenziano G; Franco R; Cozzolino I
    J Clin Pathol; 2022 Jan; 75(1):45-49. PubMed ID: 33509946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX10 expression distinguishes desmoplastic melanoma from its histologic mimics.
    Palla B; Su A; Binder S; Dry S
    Am J Dermatopathol; 2013 Jul; 35(5):576-81. PubMed ID: 23291581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
    Pluot M; Joundi A; Grosshans E
    Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of HMB45, MelanA and SOX10 is rare in non-small cell lung cancer.
    Kriegsmann M; Kriegsmann K; Harms A; Longuespée R; Zgorzelski C; Leichsenring J; Muley T; Winter H; Kazdal D; Goeppert B; Warth A
    Diagn Pathol; 2018 Sep; 13(1):68. PubMed ID: 30205833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathologic and molecular characteristics of malignant gastrointestinal neuroectodermal tumors].
    Zhao M; Zhao TW; Ma J; Wu CY; Chen L; Ru GQ; He XL
    Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):750-755. PubMed ID: 29136686
    [No Abstract]   [Full Text] [Related]  

  • 20. Acral lentiginous melanoma in situ: a study of nine cases.
    Kwon IH; Lee JH; Cho KH
    Am J Dermatopathol; 2004 Aug; 26(4):285-9. PubMed ID: 15249858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.